Thomas Kipps, MD, PhD

Thomas Kipps, MD, PhD

Professor of MedicineUC San Diego Moores Cancer Center

Dr. Thomas Kipps is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Deputy Director of Research Operations at the UC San Diego Moores Cancer Center. He received his Ph.D. in Immunology and M.D. from Harvard University and had his residency and fellowship training in Internal Medicine, Hematology and Genetics at Stanford University.

Dr. Kipps has a national and international reputation for his work in cancer research, immunology, and gene therapy. He has been a leader in the field for many years, and has helped to develop standardized treatment protocols. He is the author of more than 300 publications and is the PI on several peer-reviewed grants, including an award from NCI/NIH to fund the Chronic Lymphocytic Leukemia Research Consortium (CRC). The CRC involves collaboration with eight other Cancer Centers around the United States and the UK. Dr. Kipps is also the Director of the Blood Cancer Research Fund at the UC San Diego Moores Cancer Center. The Blood Cancer Research Fund concentrates on developing cures for all types of blood related cancers, specifically Chronic Lymphocytic Leukemia (CLL).

Dr. Kipps has over 20 years of experience in combining research and clinical care responsibilities.
As deputy director of research operations, Dr. Kipps is working to further integrate basic and translational research investigators at the Moores Cancer Center with clinical investigators, epidemiologists, and physicians offering state-of-the art therapies for patients with various forms of cancer.

Disclosures: Board of Directors/Advisory Board: Pharmacyclics, AbbVie Inc., Janssen Pharmaceuticals. Grant/Research Support: Pharmacyclics, AbbVie Inc., Breast Cancer Research Foundation (BCRF). Stock Options/Shareholder: Oncternal Therapeutics. (As of 4/26/23)

Related